Previous Article | Next Article 
Journal of Clinical Microbiology, January 1999, p. 110-116, Vol. 37, No. 1
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Efficiencies of Four Versions of the AMPLICOR HIV-1 MONITOR Test
for Quantification of Different Subtypes of Human Immunodeficiency
Virus Type 1
K.
Triques,1,*
J.
Coste,2
J. L.
Perret,3
C.
Segarra,2
E.
Mpoudi,4
J.
Reynes,5
E.
Delaporte,1
A.
Butcher,6
K.
Dreyer,6,
S.
Herman,6
J.
Spadoro,6 and
M.
Peeters1
Laboratoire Rétrovirus,
ORSTOM,1
Laboratoire de Biologie
Moléculaire, ETS Languedoc-Rousillon,2
and
Hôpital Gui de Chauliac,5
Montpellier, and
Hôpital Laveran,
Marseille,3 France;
Hôpital
Militaire, Yaounde, Cameroon4; and
Roche Molecular Systems, Branchburg, New
Jersey6
Received 23 April 1998/Returned for modification 12 June
1998/Accepted 1 October 1998
Three versions of a commercial human immunodeficiency virus
(HIV) type 1 (HIV-1) load test (the AMPLICOR HIV-1 MONITOR
Test versions 1.0, 1.0+, and 1.5; Roche Diagnostics, Branchburg, N.J.) were evaluated for their ability to detect and quantify HIV-1 RNA of
different genetic subtypes. Plasma samples from 96 patients infected
with various subtypes of HIV-1 (55 patients infected with subtype A, 9 with subtype B, 21 with subtype C, 2 with subtype D, 7 with subtype E,
and 2 with subtype G) and cultured virus from 29 HIV-1 reference
strains (3 of subtype A, 6 of subtype B, 5 of subtype C, 3 of subtype
D, 8 of subtype E, 3 of subtype F, and 1 of subtype G) were tested.
Detection of subtypes A and E was significantly improved with versions
1.0+ and 1.5 compared to that with version 1.0, whereas detection of
subtypes B, C, D, and G was equivalent with the three versions.
Versions 1.0, 1.0+, and 1.5 detected 65, 98, and 100% of the subtype
A-infected samples from patients, respectively, and 71, 100, and 100%
of the subtype E-infected samples from patients, respectively. Version 1.5 yielded a significant increase in viral load for samples infected with subtypes A and E (greater than 1 log10 HIV RNA
copies/ml). For samples infected with subtype B, C, and D and tested
with version 1.5, only a slight increase in viral load was observed (<0.5 log10). We also evaluated a prototype automated
version of the test that uses the same PCR primers as version 1.5. The results with the prototype automated test were highly correlated with
those of the version 1.5 test for all subtypes, but were lower overall.
The AMPLICOR HIV-1 MONITOR Test, version 1.5, yielded accurate
measurement of the HIV load for all HIV-1 subtypes tested, which should
allow the test to be used to assess disease prognosis and response to
antiretroviral treatment in patients infected with a group M HIV-1 subtype.
*
Corresponding author. Mailing address: ORSTOM
Laboratoire Rétrovirus, 911 Ave. Agropolis, B.P. 5045, 34032 Montpellier Cedex 1, France. Phone: 33-4-6741-6297. Fax:
33-4-6761-9450. E-mail: triques{at}mpl.orstom.fr.
Present address: Department of Infectious Diseases, University of
Rochester Medical Center, Rochester, NY 14642.
Journal of Clinical Microbiology, January 1999, p. 110-116, Vol. 37, No. 1
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Read, J. S., and the Committee on Pediatric AIDS,
(2007). Diagnosis of HIV-1 Infection in Children Younger Than 18 Months in the United States. Pediatrics
120: e1547-e1562
[Abstract]
[Full Text]
-
Oliver, A. R., Pereira, S. F., Clark, D. A.
(2007). Comparative Evaluation of the Automated Roche TaqMan Real-Time Quantitative Human Immunodeficiency Virus Type 1 RNA PCR Assay and the Roche AMPLICOR Version 1.5 Conventional PCR Assay. J. Clin. Microbiol.
45: 3616-3619
[Abstract]
[Full Text]
-
Foulongne, V., Montes, B., Didelot-Rousseau, M.-N., Segondy, M.
(2006). Comparison of the LCx Human Immunodeficiency Virus (HIV) RNA Quantitative, RealTime HIV, and COBAS AmpliPrep-COBAS TaqMan Assays for Quantitation of HIV Type 1 RNA in Plasma.. J. Clin. Microbiol.
44: 2963-2966
[Abstract]
[Full Text]
-
Garcia-Diaz, A., Clewley, G. S., Booth, C. L., Labett, W., McAllister, N., Geretti, A. M.
(2006). Comparative Evaluation of the Performance of the Abbott Real-Time Human Immunodeficiency Virus Type 1 (HIV-1) Assay for Measurement of HIV-1 Plasma Viral Load following Automated Specimen Preparation.. J. Clin. Microbiol.
44: 1788-1791
[Abstract]
[Full Text]
-
Swanson, P., de Mendoza, C., Joshi, Y., Golden, A., Hodinka, R. L., Soriano, V., Devare, S. G., Hackett, J. Jr.
(2005). Impact of Human Immunodeficiency Virus Type 1 (HIV-1) Genetic Diversity on Performance of Four Commercial Viral Load Assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT. J. Clin. Microbiol.
43: 3860-3868
[Abstract]
[Full Text]
-
Tobin, N. H., Learn, G. H., Holte, S. E., Wang, Y., Melvin, A. J., McKernan, J. L., Pawluk, D. M., Mohan, K. M., Lewis, P. F., Mullins, J. I., Frenkel, L. M.
(2005). Evidence that Low-Level Viremias during Effective Highly Active Antiretroviral Therapy Result from Two Processes: Expression of Archival Virus and Replication of Virus. J. Virol.
79: 9625-9634
[Abstract]
[Full Text]
-
Jackson, J. B., Piwowar-Manning, E., Johnson-Lewis, L., Bassett, R., Demeter, L. M., Brambilla, D.
(2004). Comparison of Versions 1.0 AND 1.5 of the UltraSensitive AMPLICOR HIV-1 MONITOR Test for Subjects with Low Viral Load. J. Clin. Microbiol.
42: 2774-2776
[Abstract]
[Full Text]
-
Brambilla, D. J., Jennings, C., Morack, R., Granger, S., Bremer, J. W.
(2004). Comparison of the Sensitivities of the Version 1.5 and Version 1.0 Ultrasensitive Roche AMPLICOR HIV-1 MONITOR Kits at Low Concentrations of Human Immunodeficiency Virus RNA. J. Clin. Microbiol.
42: 2819-2820
[Abstract]
[Full Text]
-
Xu, M., Chan, Y., Fischer, S. H., Remaley, A. T.
(2004). Automated Procedure for Improving the RNA Isolation Step in Viral Load Testing for Human Immunodeficiency Virus. J. Clin. Microbiol.
42: 439-440
[Abstract]
[Full Text]
-
Treadwell, T. L, Fleisher, J.
(2003). Underestimation of HIV-1 Plasma Viral Burden in Patients Who Acquire Infection Abroad: The Experience in a Community Hospital Clinic. Arch Intern Med
163: 1613-1614
[Abstract]
[Full Text]
-
Antunes, R., Figueiredo, S., Bartolo, I., Pinheiro, M., Rosado, L., Soares, I., Lourenco, H., Taveira, N.
(2003). Evaluation of the Clinical Sensitivities of Three Viral Load Assays with Plasma Samples from a Pediatric Population Predominantly Infected with Human Immunodeficiency Virus Type 1 Subtype G and BG Recombinant Forms. J. Clin. Microbiol.
41: 3361-3367
[Abstract]
[Full Text]
-
Ginocchio, C. C., Kemper, M., Stellrecht, K. A., Witt, D. J.
(2003). Multicenter Evaluation of the Performance Characteristics of the NucliSens HIV-1 QT Assay Used for Quantitation of Human Immunodeficiency Virus Type 1 RNA. J. Clin. Microbiol.
41: 164-173
[Abstract]
[Full Text]
-
Si-Mohamed, A., Andreoletti, L., Colombet, I., Carreno, M.-P., Lopez, G., Chatelier, G., Kazatchkine, M. D., Belec, L.
(2001). Quantitation of Human Immunodeficiency Virus Type 1 (HIV-1) RNA in Cell-Free Cervicovaginal Secretions: Comparison of Reverse Transcription-PCR Amplification (AMPLICOR HIV-1 MONITOR 1.5) with Enhanced-Sensitivity Branched-DNA Assay (Quantiplex 3.0). J. Clin. Microbiol.
39: 2055-2059
[Abstract]
[Full Text]
-
Holguín, A., Aracil, B., Álvarez, A., Barros, C., Soriano, V.
(2001). Prevalence of Human Immunodeficiency Virus Type 1 (HIV-1) Non-B Subtypes in Foreigners Living in Madrid, Spain, and Comparison of the Performances of the AMPLICOR HIV-1 MONITOR Version 1.0 and the New Automated Version 1.5. J. Clin. Microbiol.
39: 1850-1854
[Abstract]
[Full Text]
-
Swanson, P., Soriano, V., Devare, S. G., Hackett, J. Jr.
(2001). Comparative Performance of Three Viral Load Assays on Human Immunodeficiency Virus Type 1 (HIV-1) Isolates Representing Group M (Subtypes A to G) and Group O: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR Version 1.5, and Quantiplex HIV-1 RNA Version 3.0. J. Clin. Microbiol.
39: 862-870
[Abstract]
[Full Text]
-
Yoshida, S., Yusa, N., Sato, N., Goto, M., Iwamoto, A.
(2000). Some problems found in HIV-1 RNA quantification. J. Clin. Pathol.
53: 645-646
[Full Text]
-
Elbeik, T., Charlebois, E., Nassos, P., Kahn, J., Hecht, F. M., Yajko, D., Ng, V., Hadley, K.
(2000). Quantitative and Cost Comparison of Ultrasensitive Human Immunodeficiency Virus Type 1 RNA Viral Load Assays: Bayer bDNA Quantiplex Versions 3.0 and 2.0 and Roche PCR Amplicor Monitor Version 1.5. J. Clin. Microbiol.
38: 1113-1120
[Abstract]
[Full Text]
-
Jagodzinski, L. L., Wiggins, D. L., McManis, J. L., Emery, S., Overbaugh, J., Robb, M., Bodrug, S., Michael, N. L.
(2000). Use of Calibrated Viral Load Standards for Group M Subtypes of Human Immunodeficiency Virus Type 1 To Assess the Performance of Viral RNA Quantitation Tests. J. Clin. Microbiol.
38: 1247-1249
[Abstract]
[Full Text]
-
Christopherson, C., Kidane, Y., Conway, B., Krowka, J., Sheppard, H., Kwok, S.
(2000). PCR-Based Assay To Quantify Human Immunodeficiency Virus Type 1 DNA in Peripheral Blood Mononuclear Cells. J. Clin. Microbiol.
38: 630-634
[Abstract]
[Full Text]
-
Abravaya, K., Esping, C., Hoenle, R., Gorzowski, J., Perry, R., Kroeger, P., Robinson, J., Flanders, R.
(2000). Performance of a Multiplex Qualitative PCR LCx Assay for Detection of Human Immunodeficiency Virus Type 1 (HIV-1) Group M Subtypes, Group O, and HIV-2. J. Clin. Microbiol.
38: 716-723
[Abstract]
[Full Text]
-
Michael, N. L., Herman, S. A., Kwok, S., Dreyer, K., Wang, J., Christopherson, C., Spadoro, J. P., Young, K. K. Y., Polonis, V., McCutchan, F. E., Carr, J., Mascola, J. R., Jagodzinski, L. L., Robb, M. L.
(1999). Development of Calibrated Viral Load Standards for Group M Subtypes of Human Immunodeficiency Virus Type 1 and Performance of an Improved AMPLICOR HIV-1 MONITOR Test with Isolates of Diverse Subtypes. J. Clin. Microbiol.
37: 2557-2563
[Abstract]
[Full Text]
-
Stranford, S. A., Ong, J. C., Martinez-Marino, B., Busch, M., Hecht, F. M., Kahn, J., Levy, J. A.
(2001). Reduction in CD8+ cell noncytotoxic anti-HIV activity in individuals receiving highly active antiretroviral therapy during primary infection. Proc. Natl. Acad. Sci. USA
98: 597-602
[Abstract]
[Full Text]